Glucosamine's Effect on Chondrocytes
Author Information
Author(s): Scotto d'Abusco Anna, Calamia Valentina, Cicione Claudia, Grigolo Brunella, Politi Laura, Scandurra Roberto
Primary Institution: Sapienza University of Roma
Hypothesis
Can glucosamine inhibit production of matrix metalloproteinases (MMPs) by affecting IL-1β-induced MAPK activation?
Conclusion
Glucosamine inhibits IL-1β-induced expression of MMP-1, MMP-3, and MMP-13 in human chondrocytes by affecting MAPK phosphorylation.
Supporting Evidence
- Glucosamine reduced MMP-1 and MMP-13 mRNA expression after IL-1β stimulation.
- 10 mmol/l glucosamine significantly decreased MMP protein levels.
- Glucosamine inhibited phosphorylation of JNK and p38 MAPK.
Takeaway
Glucosamine helps protect cartilage by stopping certain proteins that break it down when there's inflammation.
Methodology
The study used human chondrocytes treated with glucosamine and stimulated with IL-1β, measuring MMP expression and MAPK phosphorylation.
Limitations
The concentrations of glucosamine and IL-1β used were higher than those typically found in vivo.
Participant Demographics
Healthy human donors provided chondrocytes.
Statistical Information
P-Value
p<0.05 for MMP1 and p<0.03 for MMP-13
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website